Search Within

Juan Qiu

Formats
  1. Meeting Abstract (15)
  2. Journal Article (9)
Groups
  1. Department of Medicine (24)
  2. GSK Faculty (24)
  3. Sloan Kettering Institute Postdocs (24)
  4. Solid Tumor Oncology Division (24)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (22)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (21)

More Groups

People
  1. Elisa De Stanchina (23)
  2. Charles Rudin (21)
  3. Alvaro Quintanal Villalonga (20)
  4. Yingqian Zhan (19)
  5. Parvathy Manoj (17)
  6. Richard Koche (15)

More People

Years
  1. 2024 (6)
  2. 2023 (2)
  3. 2022 (7)
  4. 2021 (7)
  5. 2020 (1)
  6. 2011 (1)
Publications
  1. Journal of Thoracic Oncology (6)
  2. Cancer Research (5)
  3. Annals of Oncology (4)
  4. Journal of Clinical Oncology (2)
  5. Journal of Hematology & Oncology (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. Elsevier Inc. (6)
  3. Oxford University Press (4)
  4. American Society of Clinical Oncology (2)
  5. Biomed Central Ltd (2)
  6. Cell Press (2)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Egger, J. V.; Bhanot, U.; Qiu, J.; De Stanchina, E.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Exportin 1 as a therapeutic target against chemoresistance in small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Bhanot, U.; Qiu, J.; de Stanchina, E.; Koche, R. P.; Poirier, J. T.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class I antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC
    Journal Article

    Nguyen, E. M.; Taniguchi, H.; Chan, J. M.; Zhan, Y. A.; Chen, X.; Qiu, J.; de Stanchina, E.; Allaj, V.; Shah, N. S.; Uddin, F.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
    Journal Article

    Su, W.; Mukherjee, R.; Yaeger, R.; Son, J.; Xu, J.; Na, N.; Timaul, N. M.; Hechtman, J.; Paroder, V.; Lin, M.; more...
    Molecular Cell (2022)

    Fulltext@MSK | Save
  • Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Chavan, S. S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Meng, F.; Uddin, F.; Manoj, P.; Donoghue, M. T. A.; Won, H. H.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y.; Hasan, M.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • CRISPR screen reveals XPO1 as a therapeutic target strongly sensitizing to first and second line therapy in small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, Á.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Ciampricotti, M.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer
    Meeting Abstract

    Quintanal‐Villalonga, Á.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J. M.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save